Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA TrialTheodore W. Laetsch, Stephan A. Grupp, Henrique Bittencourt et al.|Journal of Clinical Oncology|2022Cited by 369
S1618 TISAGENLECLEUCEL APPEARS EFFECTIVE AND SAFE IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA WITH HIGH‐RISK CYTOGENETIC ABNORMALITIESStephan A. Grupp, Michael A. Pulsipher, Shannon L. Maude et al.|HemaSphere|2019Cited by 2